LARIMAR THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-22.7M | $-22.8M | $83.0K | $129.0K |
| FY2020 | $-42.2M | $-42.3M | $62.0K | $2.2M |
| FY2021 | $-42.1M | $-42.4M | $333.0K | $5.5M |
| FY2022 | $-27.6M | $-27.7M | $100.0K | $6.6M |
| FY2023 | $-33.5M | $-33.6M | $164.0K | $7.6M |